Learn more about our Supply Chain work.
WASHINGTON, D.C. – To ensure production of vital medical devices and diagnostic tests during this critical time and to help prevent future supply chain issues, the Advanced Medical Technology Association® (AdvaMed®) announced that…
WASHINGTON, D.C. – As part of the medical technology industry’s multi-front battle to combat the coronavirus (COVID-19) pandemic, today the Advanced Medical Technology Association® (AdvaMed®) announced the launch of a new…
WASHINGTON, D.C. – The Advanced Medical Technology Association® announced today that its member respiratory device companies have dramatically expanded the limits of their present production capacity in responding to the…
Scott Whitaker, AdvaMed®’s President & CEO, recently joined host David Westin on Bloomberg Radio’s “Balance of Power” program to provide a national audience with an update on how the medical…
We are all adapting to an uncertain new reality as the COVID-19 pandemic changes the way we work and live. Business leaders at all levels are sharing the challenges they’re…
WASHINGTON, D.C. – Today, AdvaMed® President and CEO Scott Whitaker released a statement applauding congressional passage of the Coronavirus Aid, Relief, and Economic Security (CARES) Act.
WASHINGTON, D.C. – Since the onset of the coronavirus (COVID-19) outbreak, at least 31 AdvaMed® member companies have donated medical products worth approximately $26.8 million and made cash donations worth $4.1…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) this week urged the U.S. EPA to reassess its risk assessment value for ethylene oxide (EtO), arguing the threshold is neither…
The closure of medical device sterilization facilities will disrupt the health care supply chain in every state and territory in the US and cause serious public health consequences that will…